Table 2. The quality of life in DR patients or control subjects, as determined on the 8 subscales of SF-36 Questionnaire.
Patients |
Controls |
Two-factorial analysis of variance |
|||||
NPDR | PDR | C- NPDR | C- PDR | Dx | P/C | Dx×P/C | |
Body health | 70.12±20.75 | 57.33±14.76 | 76.72±19.54 | 77.24±17.89 | 1.5 | 12.6b | 1.9 |
Body role function | 46.12±42.16 | 36.25±32.68 | 52.11±22.84 | 53.53±20.64 | 1.7 | 3.9a | 0.2 |
Body pain | 68.32±24.16 | 59.74±18.77 | 70.64±20.09 | 71.32±20.46 | 0.6 | 2.2 | 0.9 |
General health | 47.74±14.64 | 38.13±10.94 | 57.88±19.76 | 55.39±19.81 | 4.2 | 8.2b | 0.6 |
Vigour | 60.55±19.98 | 51.62±15.79 | 62.14±14.23 | 64.24±13.92 | 4.4 | 2.1 | 1.2 |
Social function | 64.33±19.94 | 55.24±15.35 | 66.32±20.11 | 66.86±21.42 | 1.1 | 9.8b | 0 |
Emotion role function | 48.34±37.35 | 40.11±32.67 | 56.24±36.21 | 56.64±36.52 | 4.9a | 14.3b | 0 |
Mental health | 60.11±18.84 | 49.11±12.32 | 67.76±18.92 | 65.59±18.13 | 2.3 | 12.6b | 1.4 |
Dx: diagnosis; P/C: patients vs respective controls; aP<0.05, bP<0.01 vs controls.